Meet with NCI SBIR: Experts in Commercialization Assistance & Federal Funds

SBIR/STTR experts from the National Cancer Institute will be available to discuss the benefits of pursuing federal funding through the SBIR/STTR program.

Join experts from the National Cancer Institute on Wednesday, March 20th at 8:45 AM CT for the upcoming “Meet with NCI SBIR: Federal Funding and Commercialization Assistance to Support the Next Generation of Biotech Innovation” event, cohosted by Chicago Biomedical Consortium and Portal Innovations.

Following introductions by the hosting organizations, Program Director Sarra Djemil from the National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Development Center will provide a detailed overview of funding opportunities and resources to help biotech innovators in the Chicago area move their projects toward commercialization. After the main presentation, attendees will have the chance to participate in a live Q&A session with the speakers.

Topics to be covered include:

• SBIR/STTR eligibility requirements
• NIH SBIR/STTR process and new cancer-focused funding opportunities from NCI
• NCI SBIR/STTR initiatives such as the I-Corps at NIH Entrepreneurship Program, Applicant Assistant Program, etc.
• Practical strategies on how to successfully submit competitive research proposals

Attendees will also have the opportunity to book one-on-one meetings with NCI program staff to discuss their projects. If you would like to be considered for a one-on-one meeting, please contact Bryce Geiling ([email protected]) by Wednesday, March 13, with a one-page summary of your company and technology. Once confirmed, meeting information will be sent to you. For questions regarding the event, please contact Nancy Tyrrell ([email protected])